Biotech

All Articles

ArsenalBio raises $325M, turns away from past lead resource

.Collection Biosciences is actually proceeding up. The tissue therapy provider has actually added on...

Lilly- backed weight reduction biotech data IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has submitted to...

Aelis' marijuana use medicine fails period 2b, steering Indivior to rethink $100M possibility

.Aelis Farma's chances of protecting a fast, positive selection on a $100 million possibility repaym...

ProKidney stops phase 3 test not needed to have for tissue treatment permission

.ProKidney has actually ceased among a set of phase 3 tests for its cell therapy for kidney health c...

Vaxcyte rises on 'remarkable' 31-valent PCV gain against Pfizer

.Vaxcyte introduced what experts called "spectacular" stage 1/2 information for its 31-valent pneumo...

Recursion's brain condition trial reveals scant proof of effectiveness

.Recursion has actually stumbled via a very early exam of its tech-enabled technique to drug discove...

Acepodia, Pfizer click on together for chemistry-based cell therapy

.Call it a situation of great chemistry: Acepodia, a biotech based upon Nobel Prize-winning scientif...

Praxis epilepsy drug lowers seizures in stage 2 litigation

.Practice Precision Medicines has racked up another midphase gain in epilepsy this year, with its ow...

Three officers surrender as Dyne articles combined records for DMD prospect

.After getting away a professional hold numerous years back, Dyne Therapy has revealed brand new per...

Arrowhead fires off period 3 records in uncommon metabolic illness in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually presented its give in front of a possible face-off along wit...